We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Dechra Pharmaceuticals Plc | LSE:DPH | London | Ordinary Share | GB0009633180 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3,866.00 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
06/9/2021 07:46 | When these highly valued stocks on a crazy p.e disappoint, they do get hit. | montyhedge | |
06/9/2021 07:33 | The beneficial impact of Covid is not to be underestimated but the company has clearly done a lot to enhance margins by operational improvements.the shares have been very strong since the interims and a pullback was to be expected especially since there may have anticipatory buying ahead of FTSE 100 inclusion which ultimately failed to occur.The buy case remains very much in tact.OutlookAs we start the new financial year trading remains strong with the momentum and market penetration seen in the second half of the prior financial year continuing. We have made significant operational improvements by strengthening our infrastructure and by investment in our greatest resource, our people. Although COVID-19 related travel restrictions have limited acquisition activity, we have still been able to identify and progress numerous strategic opportunities to strengthen our product portfolio and development pipeline. We therefore remain confident in our ability to successfully execute our strategy and in our future prospects. | steeplejack | |
06/9/2021 06:56 | In line, ok figures, nothing to get really excited about, I thought. | montyhedge | |
05/9/2021 09:30 | Dechra narrowly missed out on promotion to FTSE 100 which partly explains price weakness on Friday.Final figures tomorrow,6 Sept. | steeplejack | |
30/8/2021 08:53 | DPH is being touted for a potential promotion to the FTSE100. This is because BHP is delisting and JET is reclassified as non-UK because most trading is now is US following a takeover. | whatja | |
25/8/2021 12:22 | Will it go up on ft 100 entry? | mellorscarthwaite | |
25/8/2021 07:22 | DavROs I can almost feel your finger hovering over the sell button ;-) | blue59 | |
23/8/2021 18:30 | I won't post any more ATHs so much as it seems a) I maybe alone and b) it won't go up for ever and c) it may be winding people up. Suffice to say I'm still holding a full sized position - good luck to those that have continued holding | davr0s | |
20/8/2021 17:34 | And another - it has taken me quite a few years to psychologically be able to keep holding a full position as it grinds up. I will suffer at some point but it's already gone a long way up since people were bailing, calling tops etc | davr0s | |
18/8/2021 15:08 | Ftse 100 could have a new Member ? | mellorscarthwaite | |
18/8/2021 07:58 | I’ll give advance warning next time! I also backed an odds on England win in the Test! ho hum! I bought FLTR yesterday, so a possible short! | blue59 | |
18/8/2021 07:41 | Lol, so tell us what else you have sold recently | davr0s | |
18/8/2021 07:37 | There is only one reason this is continuing to climb, it’s not take over possibilities, not cash position or product demand, it’s simply because…… | blue59 | |
17/8/2021 18:14 | Another closing ATH. I never argue with a share doing this. Still holding full position | davr0s | |
16/8/2021 13:12 | The stock commands a substantial premium in the UK simply because it enjoys good cash flow and solid product demand.As evidenced by the relatively flat performance of the FTSE 100 over the last twenty years,the UK simply doesn’t have the same number of companies likely to enjoy high sustained growth that you can find in the US for example.You can buy a cyclical like BHP ,a steady eddy like Legal & General or even a company like BATs which became by default the most consistent FTSE 100 outperformer for a decade post the tech crash.However,that you might in the recent past have had to consider buying a cigarette manufacturer to achieve outperformance,sort of confirms the lack of good investment opportunities in the UK!Thing is,a conglomerate somewhere in the world,might want to snap up Dechra for the earnings surety it can provide.All that said,the rating is heady. | steeplejack | |
16/8/2021 10:08 | Just back from vets, £35 for eye drops for the dog.Think I will try and recover it by buying into Dechra. | andyadvfn1 | |
14/8/2021 17:25 | Another ATH on a closing basis | davr0s | |
03/8/2021 18:17 | Still holding full position. Never predict but just ride the trend. Market can keep going up further than expected regardless of all the research, analysis etc that a lot of people do | davr0s | |
03/8/2021 14:37 | I bailed at 3600 thinking it was getting too frothy...and regret it!Very hard to justify this price however the business is growing consistently and so long as it keeps it up, one could argue the price is valid. I wouldn't buy back at this level but I'd probably hold until the price starts to show weakness. | nfvda | |
03/8/2021 09:21 | I suppose the buyers who crunch the numbers are banking on continued further growth. And the momentum buyers follow in their slipstream. | lindowcross | |
30/7/2021 17:49 | Is that another ATH I see today? | davr0s | |
23/7/2021 15:15 | Same here switching out of p.e 149 to Hikma Pharmaceuticals forecast pe16. | montyhedge | |
23/7/2021 12:02 | Air's too thin for me up here, so I'm taking a break from this one for now. | thamestrader | |
23/7/2021 07:50 | I switched out of Dechra into Hikma may be wrong had a good run on this.Hopefully Hikma Pharmaceuticals do the same, just feel more upside on a low valuation. | montyhedge |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions